
    
      Study participants who are previously immunized with JE-CV vaccine will receive a booster
      dose of the JE-CV vaccine and will be followed up for 5 years for immunogenicity.

      The control (JE-CV na√Øve) participants will receive either one dose of JE-CV vaccine or one
      dose of varicella vaccine.

      All participants will be monitored for safety for 6 month post-vaccination.
    
  